These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1122 related articles for article (PubMed ID: 7768881)

  • 21. A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential.
    Dey D; Medicherla S; Neogi P; Gowri M; Cheng J; Gross C; Sharma SD; Reaven GM; Nag B
    Metabolism; 2003 Aug; 52(8):1012-8. PubMed ID: 12898466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. INT131: a selective modulator of PPAR gamma.
    Motani A; Wang Z; Weiszmann J; McGee LR; Lee G; Liu Q; Staunton J; Fang Z; Fuentes H; Lindstrom M; Liu J; Biermann DH; Jaen J; Walker NP; Learned RM; Chen JL; Li Y
    J Mol Biol; 2009 Mar; 386(5):1301-11. PubMed ID: 19452630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma.
    Wang M; Wise SC; Leff T; Su TZ
    Diabetes; 1999 Feb; 48(2):254-60. PubMed ID: 10334298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake.
    Hamm JK; el Jack AK; Pilch PF; Farmer SR
    Ann N Y Acad Sci; 1999 Nov; 892():134-45. PubMed ID: 10842659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists.
    Gerhold DL; Liu F; Jiang G; Li Z; Xu J; Lu M; Sachs JR; Bagchi A; Fridman A; Holder DJ; Doebber TW; Berger J; Elbrecht A; Moller DE; Zhang BB
    Endocrinology; 2002 Jun; 143(6):2106-18. PubMed ID: 12021175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RGS2 promotes adipocyte differentiation in the presence of ligand for peroxisome proliferator-activated receptor gamma.
    Nishizuka M; Honda K; Tsuchiya T; Nishihara T; Imagawa M
    J Biol Chem; 2001 Aug; 276(32):29625-7. PubMed ID: 11418611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic and additional vascular effects of thiazolidinediones.
    Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
    Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.
    Oberfield JL; Collins JL; Holmes CP; Goreham DM; Cooper JP; Cobb JE; Lenhard JM; Hull-Ryde EA; Mohr CP; Blanchard SG; Parks DJ; Moore LB; Lehmann JM; Plunket K; Miller AB; Milburn MV; Kliewer SA; Willson TM
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6102-6. PubMed ID: 10339548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of ligands for the nuclear peroxisome proliferator-activated receptors.
    Willson TM; Lehmann JM; Kliewer SA
    Ann N Y Acad Sci; 1996 Dec; 804():276-83. PubMed ID: 8993550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gene encoding the Acyl-CoA-binding protein is activated by peroxisome proliferator-activated receptor gamma through an intronic response element functionally conserved between humans and rodents.
    Helledie T; Grøntved L; Jensen SS; Kiilerich P; Rietveld L; Albrektsen T; Boysen MS; Nøhr J; Larsen LK; Fleckner J; Stunnenberg HG; Kristiansen K; Mandrup S
    J Biol Chem; 2002 Jul; 277(30):26821-30. PubMed ID: 12015306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
    Koh EH; Kim MS; Park JY; Kim HS; Youn JY; Park HS; Youn JH; Lee KU
    Diabetes; 2003 Sep; 52(9):2331-7. PubMed ID: 12941773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.
    Young PW; Buckle DR; Cantello BC; Chapman H; Clapham JC; Coyle PJ; Haigh D; Hindley RM; Holder JC; Kallender H; Latter AJ; Lawrie KW; Mossakowska D; Murphy GJ; Roxbee Cox L; Smith SA
    J Pharmacol Exp Ther; 1998 Feb; 284(2):751-9. PubMed ID: 9454824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.
    Tontonoz P; Singer S; Forman BM; Sarraf P; Fletcher JA; Fletcher CD; Brun RP; Mueller E; Altiok S; Oppenheim H; Evans RM; Spiegelman BM
    Proc Natl Acad Sci U S A; 1997 Jan; 94(1):237-41. PubMed ID: 8990192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
    Berger J; Bailey P; Biswas C; Cullinan CA; Doebber TW; Hayes NS; Saperstein R; Smith RG; Leibowitz MD
    Endocrinology; 1996 Oct; 137(10):4189-95. PubMed ID: 8828476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
    Camp HS; Li O; Wise SC; Hong YH; Frankowski CL; Shen X; Vanbogelen R; Leff T
    Diabetes; 2000 Apr; 49(4):539-47. PubMed ID: 10871190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic potentiation of thiazolidinedione-induced ST 13 preadipocyte differentiation by RAR synergists.
    Sato M; Yajima Y; Kawashima S; Tanaka K; Kagechika H
    Biochem Biophys Res Commun; 2001 Jan; 280(3):646-51. PubMed ID: 11162570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?
    Starkey K; Heufelder A; Baker G; Joba W; Evans M; Davies S; Ludgate M
    J Clin Endocrinol Metab; 2003 Jan; 88(1):55-9. PubMed ID: 12519830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells.
    Johnson TE; Vogel R; Rutledge SJ; Rodan G; Schmidt A
    Endocrinology; 1999 Jul; 140(7):3245-54. PubMed ID: 10385421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.
    Gavrilova O; Haluzik M; Matsusue K; Cutson JJ; Johnson L; Dietz KR; Nicol CJ; Vinson C; Gonzalez FJ; Reitman ML
    J Biol Chem; 2003 Sep; 278(36):34268-76. PubMed ID: 12805374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation.
    Hutley LJ; Newell FM; Joyner JM; Suchting SJ; Herington AC; Cameron DP; Prins JB
    Eur J Clin Invest; 2003 Jul; 33(7):574-81. PubMed ID: 12814394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.